検索
Novartis AG
NVSウォッチリストに追加
154.440USD
-1.700-1.09%
終値 07-23 16:00（ET）15分遅れの株価
293.55B時価総額
21.98直近12ヶ月PER
詳細情報 Novartis AG 企業名
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Novartis AGの企業情報
企業コードNVS
会社名Novartis AG
上場日May 07, 2001
最高経営責任者「CEO」Narasimhan (Vasant)
従業員数75883
証券種類Depository Receipt
決算期末May 07
本社所在地Lichtstrasse 35
都市BASEL
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国Switzerland
郵便番号4056
電話番号41613241111
ウェブサイトhttps://www.novartis.com/
企業コードNVS
上場日May 07, 2001
最高経営責任者「CEO」Narasimhan (Vasant)
Novartis AGの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Patrice Bula
Mr. Patrice Bula
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
よくある質問
Novartis AGの上位5名の株主は誰ですか？
Novartis AGの上位5名の株主は以下のとおりです。Mr. Harry Kirsch
Novartis AG（NVS）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Novartis AGの株式を保有している機関は2164社あり、保有株式の総市場価値は約143.01Mで、全体の7.49%を占めています。2025Q4と比較して、機関の持ち株は-1630148.00増加しています。
Novartis AGの最大の収益源は何ですか？
2026Q1において、Rest of portfolio部門がNovartis AGにとって最大の収益を生み出しており、その金額は10.02Bで、全収益の18.37%を占めています。